Abstract:Echium italicum L. is found to produce shikonin and its natural derivatives such as acetylshikonin that has cytotoxic activity on cancer cells. Thus, in vitro mass production of this plant is important for the overproduction of derivatives with the usage of hairy root cultures in bioreactor together with the inclusion of elicitors to the in vitro proliferation medium. Hence, the aims of the study concern the usage of recent SETISTM temporary immersion bioreactor systems with the application of different immersion times for the induced production of shikonin derivatives from hairy root cultures, synthesis of novel shikonin derivatives with imidazole- and indole-substituted compounds, and determination of cytotoxic activity of these new derivatives by investigation of their anti-proliferative influence on breast cancer cell lines. Within the various tested conditions, the highest proliferation of hairy roots was obtained with the inclusion of methyl jasmonate (MeJa) as an elicitor and immersion of cultures for 12 min for every 6 h. Two shikonin derivatives, acetylshikonin (ASK) and mixture of isovaleryl shikonin and 2-n-methyl-butyryl shikonin (IVS+MBS) were isolated from the extracts and characterized by HPLC, UV-Vis, mass spectroscopy, 1 H and 13 C NMR and FT-IR spectroscopy techniques. Among them, isolated acetylshikonin was modified with the inclusion of the bis-imidazole- (C34) and indole-(C36) substituted compounds. Cytotoxic activities of acetylshikonin and its novel modified ASK derivatives were evaluated on three breast cancer cell lines (MCF-7, SKBR-3, and MDA-MB-231). Overall results demostrated that both modified shikonin molecules had a more significant anti-proliferative effects on breast cancer cells than purified acetylshikonin from hairy roots of Echium italicum in the first 24 h. Moreover, all tested molecules, except 50 μM in 48 h, did not show any cytotoxic activity against breast epithelial cells (MCF-12A) at 24 h and 48 h.

Anoikis and cancer cell differentiation: novel modes of shikonin derivatives anticancer action in vitro

RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment

[Antitumor effect research progress of shikonin and its derivatives]

Shikonin induces cell cycle arrest in human gastric cancer (AGS) by early growth response 1 (Egr1)-mediated p21 gene expression

Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies

Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways

Shikonin Causes Non-apoptotic Cell Death in B16F10 Melanoma

Growth Inhibition and Induction of Apoptosis in Human Oral Squamous Cell Carcinoma Tca-8113 Cell Lines by Shikonin Was Partly Through the Inactivation of Nf-Kappa B Pathway

Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction

Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway

Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach.

A Review on Shikonin and Its Derivatives as Potent Anticancer Agents Targeted against Topoisomerases

Design, Synthesis and Anticancer Activity of Shikonin and Alkannin Derivatives with Different Substituents on the Naphthazarin Scaffold

In vitro mass production, chemical modification, and cytotoxicity of shikonin derivatives on breast cancer cells

Design, synthesis and mechanism of novel shikonin derivatives as potent anticancer agents

Shikonin Inhibits Thyroid Cancer Cell Growth and Invasiveness Through Targeting Major Signaling Pathways

Shikonin induced Apoptosis Mediated by Endoplasmic Reticulum Stress in Colorectal Cancer Cells

Shikonin and Its Derivatives: a Patent Review

Shikonin Stimulates Mitochondria‐Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer Cells

The Anti-tumor Function of Shikonin by Targeting EGFR/AKT/mTOR Signaling in Human Osteosarcoma Cells

Enhancement of NK cells proliferation and function by Shikonin